临床试验/NL-OMON26301

NL-OMON26301招募中不适用

Primary prevention of rheumatoid arthritis.

Prof.dr. B.A.C. DijkmansVUMC/Jan van Breemen Instituut0 个研究点目标入组 80 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

阶段: 不适用
状态: 招募中
发起方
入组人数: 80

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Arthritis Rheum 2004; 50: 380-6
Arthritis Rheum 2004; 50: 2423-7

研究设计

研究类型: Interventional

入排标准

入选标准

•1. Age 18-70 years for RF+, 18+ for aCCP+;
•2. Twice increased IgM-RF and/or anti-CCP with 4+ weeks interval;

排除标准

•Situations with possible false positive RF:

研究者

发起方

Prof.dr. B.A.C. DijkmansVUMC/Jan van Breemen Instituut

相似试验

Primary prevention of rheumatoid arthritisMusculoskeletal DiseasesRheumatoid arthritis

ISRCTN73232918Jan van Breemen Instituut (Netherlands)80

Prevention of RA by B cell directed therapy.pre-clinical RA

NL-OMON28176Academic Medical Center/University of Amsterdam, Amsterdam90

进行中（未招募）

Prevention of clinically manifest rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease.

EUCTR2009-010955-29-NLDivision of Clinically Immunology and Rheumatology, AMC

BeSt, BehandelStrategieën in Reumatoïde Artritis.

NL-OMON24149Dutch College of Health Insurance Companies508

Arthritis Prevention In the Pre-clinical Phase of Rheumatoid Arthritis with AbataceptTopic: Musculoskeletal disordersSubtopic: Musculoskeletal (all Subtopics)Disease: MusculoskeletalMusculoskeletal Diseases

ISRCTN46017566Guy's and St Thomas' NHS Foundation Trust213